Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Pediatr Infect Dis J. 2013 Jul;32(7):e298–e304. doi: 10.1097/INF.0b013e31828afb2a

TABLE 4.

Relation between pre-HAART to 12-month post-HAART change in immune and growth parameters and the pre-HAART to 12-month change, adjusted for baseline, in TC, LDL and HDL levels among infants with 12 months of follow-up.

TC N=68 LDL N=62 HDL N=70
Regression Coefficient Regression Coefficient Regression Coefficient
Pre-HAART to 12-month
change		 12-Month
Level^
(P-value)		 Adjusted
12-Month
Change
(P-value)		 12-Month
Level^
(P-value)		 Adjusted
12-Month
Change
(P-value)		 12-Month
Level^
(P-value)		 Adjusted
12-Month
Change
(P-value)
CD4 count per 100 cells/ml*
 0.4
(0.4)		 0.4
(0.9)		 0.1
(0.9)		 0.2
(0.8)		 0.3
(0.1)		 0.3
(0.1)
WAZ 6.7
(0.09)		 8.7
(0.03)		 4.4
(0.2)		 6.0
(0.06)		 2.7
(0.01)		 2.7§
(0.01)
HAZ 12.5
(0.03)		 14.1
(0.01)		 8.5
(0.06)		 10.1
(0.03)		 4.1
(0.007)		 4.1¥
(0.007)
*

N=67, TC; N=61, LDL; N=69, HDL.

^

P-values refer to linear regression analyses used to evaluate potential correlates of lipid levels at 12 months.

P-values refer to linear regression analyses used to evaluate potential correlates of the change in lipid level from pre-HAART to 12-months, after adjusting for pre-HAART lipid level.

§

In a model adjusted for LPV/r-use, regression coefficient=2.2 mg/dL per unit increase in pre-HAART to 12-month change in WAZ; P=0.04.

¥

In a model adjusted for LPV/r-use, regression coefficient=3.3 mg/dL per unit increase in pre-HAART to 12-month change in HAZ; P=0.03.

HAART indicates highly active antiretroviral therapy; WAZ weight-for-age Z-score; HAZ, height-for-age Z-score; TC, total cholesterol, LDL, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol; and TG, triglycerides